Company Filing History:
Years Active: 2005
Title: Bo Fredholm: Innovator in Chemotherapeutic Advancements
Introduction
Bo Fredholm is a notable inventor based in Helsingborg, Sweden. He has made significant contributions to the field of cancer treatment through his innovative approaches to chemotherapeutic drugs. His work focuses on enhancing the efficacy of existing treatments, particularly in the administration of estramustine phosphate.
Latest Patents
Fredholm holds a patent for "Methods to potentiate intravenous estramustine phosphate." This invention describes methods that enhance the therapeutic benefits of intravenous estramustine phosphate, an anti-mitotic chemotherapeutic drug known for its effectiveness against various cancers. The patent outlines a method for administering estramustine phosphate at high dosages exceeding 1300 mg as a single dose. This approach significantly improves the pharmacokinetics of the drug, allowing for better treatment outcomes. The formulation is applicable in combinational regimens with other chemotherapeutic agents, providing therapeutic advantages for treating a range of cancers, including prostate, breast, lung, colorectal, pancreatic, ovarian cancers, melanoma, and more.
Career Highlights
Fredholm's career is marked by his dedication to advancing cancer treatment methodologies. His innovative patent reflects his commitment to improving patient outcomes through enhanced drug formulations. His work has the potential to change the landscape of cancer therapy, offering new hope to patients battling various forms of the disease.
Collaborations
Fredholm has collaborated with esteemed colleagues, including Michael S Kopreski and Beryl Asp. These partnerships have contributed to the development and refinement of his innovative approaches in the field of oncology.
Conclusion
Bo Fredholm's contributions to cancer treatment through his patent on intravenous estramustine phosphate exemplify the impact of innovation in medicine. His work not only enhances the efficacy of existing treatments but also opens new avenues for therapeutic strategies against cancer.